ADJUVANT EXTENDED FIELD RADIOTHERAPY FOLLOWED BY TAXAN-PLATINUM CHEMOTHERAPY IN HIGH RISK ENDOMETRIAL CANCER PATIENTS

被引：0
|
作者：
Kreynina, J. [1 ]
Shevchenko, L. [2 ]
Kaskulova, M. [2 ]
Iksanova, A. [3 ]
Tatarnikova, O. [4 ]
机构：
[1] Russian Sci Ctr Roentgenradiol, Brachytherapy, Moscow, Russia
[2] Russian Sci Ctr Roentgenradiol, Oncogynecol, Moscow, Russia
[3] Orsk Oncol Ctr, Radiotherapy, Orsk, Russia
[4] Russian Sci Ctr Roentgenradiol, Radiol, Moscow, Russia
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2018年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCS8-1131
引用
收藏
页码：1114 / 1114
页数：1
相关论文
共 50 条
  • [41] Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer
    Greven, K
    Winter, K
    Underhill, K
    Fontenesci, J
    Cooper, J
    Burke, T
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (01): : 168 - 173
  • [42] Is Adjuvant Chemotherapy Necessary in Patients with Early Endometrial Cancer?
    Iida, Yuki
    Komatsu, Hiroaki
    Okawa, Masayo
    Osaku, Daiken
    Nosaka, Kanae
    Sato, Shinya
    Oishi, Tetsuro
    Taniguchi, Fuminori
    Harada, Tasuku
    YONAGO ACTA MEDICA, 2022, 65 (01) : 82 - 87
  • [43] Adjuvant Chemotherapy versus Radiotherapy in High-risk, Early-stage Endometrioid Endometrial Carcinoma
    Wu, Min
    Yang, Ya-nan
    Huang, Yu-hui
    Cai, Jing
    He, Xiao-qi
    Wang, Ze-hua
    CURRENT MEDICAL SCIENCE, 2022, 42 (01) : 185 - 191
  • [44] Adjuvant Chemotherapy versus Radiotherapy in High-risk, Early-stage Endometrioid Endometrial Carcinoma
    Min Wu
    Ya-nan Yang
    Yu-hui Huang
    Jing Cai
    Xiao-qi He
    Ze-hua Wang
    Current Medical Science, 2022, 42 : 185 - 191
  • [45] Adjuvant Concurrent Chemoradiation and Chemotherapy for High Risk Non-Metastatic Endometrial Cancer
    Rajan, R.
    Kunheri, D. B.
    Tatineni, D. T.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S597 - S597
  • [46] Chemotherapy as Adjuvant Treatment for Early Stage Endometrial Cancer With High Intermediate Risk Factors
    Gao, Min
    Zhang, Naiyi
    Song, Nan
    Zheng, Hong
    Yan, Xin
    Gao, Yunong
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (07) : 1285 - 1289
  • [47] A prospective study of adjuvant carboplatin and paclitaxel chemotherapy and involved field radiation in women with high-risk endometrial cancer
    Lupe, K.
    Kwon, J.
    D'Souza, D.
    Carey, M.
    Gawlik, C.
    Stitt, L.
    Whiston, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S166 - S166
  • [48] Patterns of Failures and Clinical Outcome of Patients with Early-Stage, High-Risk, Node-Negative Endometrial Cancer Treated with Surgery Followed by Adjuvant Platinum-Based Chemotherapy and Vaginal Brachytherapy
    Laliscia, Concetta
    Cosio, Stefania
    Morganti, Riccardo
    Mazzotti, Valentina
    Fabrini, Maria Grazia
    Paiar, Fabiola
    Gadducci, Angiolo
    ONCOLOGY, 2019, 96 (05) : 235 - 241
  • [49] The prognostic factor of endometrial cancer receiving adjuvant taxane-platinum chemotherapy
    Ito, Fuminori
    Furukawa, Naoto
    Tanase, Yasuhito
    Kanayama, Seiji
    Kawaguchi, Ryuji
    Yoshida, Shozo
    Kobayashi, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [50] Hyperfractionated radiotherapy followed by adjuvant chemotherapy for nasopharyngeal cancer: Report of seven cases
    Toita, T
    Ogawa, K
    Kamata, M
    Kojya, S
    Itokazu, T
    Kakinohana, Y
    Iraha, S
    Yoshinaga, M
    Zukeran, Y
    Sawada, S
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1999, 29 (03) : 160 - 163
12345